Gas Plus S.p.A.
Gas Plus S.p.A. engages in the extraction, distribution, and sale of natural gas in Italy. It is also involved in the distribution, transport, and storage of natural gas; and sells methane gas, and oil and condensates. The company was founded in 1960 and is based in Milan, Italy. Gas Plus S.p.A. is a subsidiary of US.FIN. S.r.l.
Gas Plus S.p.A. (0EMK) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, Gas Plus S.p.A. (0EMK) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Gas Plus S.p.A. - Net Assets Trend (None–None)
This chart illustrates how Gas Plus S.p.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Gas Plus S.p.A. (None–None)
The table below shows the annual net assets of Gas Plus S.p.A. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Gas Plus S.p.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Gas Plus S.p.A. Competitors by Market Cap
The table below lists competitors of Gas Plus S.p.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Windlas Biotech Limited
NSE:WINDLAS
|
$63.73 Million |
|
Micro Systemation AB Series B
LSE:0FBM
|
$63.78 Million |
|
Canyon Resources Ltd
AU:CAY
|
$63.82 Million |
|
Biosyent Inc.
PINK:BIOYF
|
$63.83 Million |
|
Imagicaaworld Entertainment Limited
NSE:IMAGICAA
|
$63.70 Million |
|
ShareHope Medicine Co Ltd
TWO:8403
|
$63.70 Million |
|
Waratah Minerals Limited
F:0FS0
|
$63.70 Million |
|
Talbros Automotive Components Limited
NSE:TALBROAUTO
|
$63.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gas Plus S.p.A.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Gas Plus S.p.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Gas Plus S.p.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Gas Plus S.p.A.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gas Plus S.p.A. (0EMK) | €- | N/A | N/A | $63.72 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |